A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay
Inexpensive, simple, rapid diagnostics are necessary for efficient detection, treatment, and mitigation of COVID-19. Assays for SARS-CoV2 using reverse transcription polymerase chain reaction (RT-PCR) offer good sensitivity and excellent specificity, but are expensive, slowed by transport to central...
Guardado en:
Autores principales: | Benjamin D. Grant, Caitlin E. Anderson, Luis F. Alonzo, Spencer H. Garing, John R. Williford, Ted A. Baughman, Rafael Rivera, Veronika A. Glukhova, David S. Boyle, Puneet K. Dewan, Bernhard H. Weigl, Kevin P. Nichols |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d6a8db8cf6548dbb67de11f5199f595 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
por: Benjamin D Grant, et al.
Publicado: (2021) -
Coronavirus nucleocapsid proteins assemble constitutively in high molecular oligomers
por: Yingying Cong, et al.
Publicado: (2017) -
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays.
por: Zahra Rikhtegaran Tehrani, et al.
Publicado: (2020) -
MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity
por: Li Wang, et al.
Publicado: (2021) -
Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
por: John T Connelly, et al.
Publicado: (2021)